Medicine and Dentistry
Aortic Valve Prosthesis
6%
Aortic Valve Stenosis
100%
Atrial Fibrillation
30%
Bovine Serum Albumin
12%
Calcium Ion
21%
Cardiovascular System
38%
Computed Tomography Angiography
6%
COVID-19
60%
Delta Wave
6%
Diabetes Mellitus
5%
Diastolic Function
12%
Drug Therapy
5%
Echocardiography
9%
Ezetimibe
9%
Hypertrophic Cardiomyopathy
30%
Hypertrophic Obstructive Cardiomyopathy
30%
Ischemic Heart Disease
30%
Isotopes of Calcium
30%
Low Density Lipoprotein Cholesterol
54%
Lung Artery Pressure
42%
Monotherapy
12%
Omicron Coronavirus Variant
30%
Percutaneous Aortic Valve Replacement
51%
Prematurity
7%
Primary Prevention
27%
Pulmonary Artery
30%
Pulmonary Embolism
6%
Pulmonary Hypertension
80%
Retrospective Study
12%
Rivaroxaban
30%
Secondary Prevention
24%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Sex Difference
33%
Somatomedin Binding Protein 2
30%
ST Segment Elevation Myocardial Infarction
52%
Statin
22%
Sudden Cardiac Death
30%
Thromboprophylaxis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
18%
All Cause Mortality
5%
Aortic Valve Stenosis
75%
Atrial Fibrillation
30%
Biological Marker
6%
Bovine Serum Albumin
30%
Cardiovascular Mortality
9%
Cerebrovascular Accident
37%
Coronavirinae
34%
Diabetes Mellitus
5%
Disease
34%
Diseases
9%
Empagliflozin
30%
Ezetimibe
9%
Heart Infarction
54%
Hospital Mortality
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Infection
9%
Long Term Survival
5%
Low Density Lipoprotein Cholesterol
24%
Lung Embolism
30%
Monotherapy
5%
Mortality Rate
9%
Non Insulin Dependent Diabetes Mellitus
30%
Pandemic
9%
Placebo
18%
Prematurity
9%
Prospective Study
9%
Pulmonary Hypertension
90%
Retrospective Study
5%
Rivaroxaban
30%
SARS Coronavirus
30%
Somatomedin Binding Protein 2
30%
ST Segment Elevation Myocardial Infarction
30%
Statin (Protein)
5%
Sudden Cardiac Death
30%
Survival Rate
15%
